https://gentaur.com/products/25203666-bmh-21 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203667-th10785 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203668-su9516 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203669-phenylacetyl-l-glutamine 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203670-dt-109 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203671-m22 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203672-u-83836e 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203673-caccinh-a01 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203674-arv-110 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203675-gw3965-hcl 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203676-cu-cpt8m 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203677-scr7-pyrazine 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203678-bi-3406 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203679-pf-06835919 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203680-cefcapene-pivoxil 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203681-dmb 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203682-thiothixene 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203683-e3330 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203684-avutometinib 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203685-fostamatinib-disodium 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203686-alpelisib 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203687-idasanutlin 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203688-pk11007 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203689-xi-011 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203690-ver-246608 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203691-sotrastaurin 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203692-r-gne-140 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203693-indacaterol-maleate 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203694-sphinx31 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203695-ritlecitinib 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203696-pritelivir 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203697-vu0810464 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203698-dinaciclib 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203699-fb23-2 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203700-nvp-2 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203701-at7519-hcl 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203702-senexin-b 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203703-sr-4835 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203704-milciclib 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203705-sw033291 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203706-tj-m2010-5 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203707-pat-1251 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203708-mz1 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203709-mreb-inhibitor-a22 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203710-cid16020046 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203711-pyrintegrin 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203712-anti-human-dll3-rovalpituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203713-anti-human-dll3-rovalpituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203714-anti-human-dll3-rovalpituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203715-anti-human-il-6ra-cd126-vobarilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203716-anti-human-il-6ra-cd126-vobarilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203717-anti-human-il-6ra-cd126-vobarilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203718-anti-human-ror1-zilovertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203719-anti-human-ror1-zilovertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203720-anti-human-ror1-zilovertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203721-anti-human-gpc3-glypican-3-codrituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203722-anti-human-gpc3-glypican-3-codrituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203723-anti-human-gpc3-glypican-3-codrituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203724-anti-human-ctla-4-cd152-ipilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203725-anti-human-ctla-4-cd152-ipilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203726-anti-human-ctla-4-cd152-ipilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203727-anti-human-erbb2-her2-cd340-disitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203728-anti-human-erbb2-her2-cd340-disitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203729-anti-human-erbb2-her2-cd340-disitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203730-anti-human-siglec-15-cd33l3-nc318-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203731-anti-human-siglec-15-cd33l3-nc318-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203732-anti-human-siglec-15-cd33l3-nc318-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203733-anti-human-il-6ra-cd126-sarilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203734-anti-human-il-6ra-cd126-sarilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203735-anti-human-il-6ra-cd126-sarilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203736-anti-human-nectin-4-enfortumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203737-anti-human-nectin-4-enfortumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203738-anti-human-nectin-4-enfortumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203739-anti-human-cxcr4-cd184-ulocuplumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203740-anti-human-cxcr4-cd184-ulocuplumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203741-anti-human-cxcr4-cd184-ulocuplumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203742-anti-human-tnfsf13b-baff-cd257-belimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203743-anti-human-tnfsf13b-baff-cd257-belimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203744-anti-human-tnfsf13b-baff-cd257-belimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203745-anti-human-b7-h1-pd-l1-cd274-mdx-1105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203746-anti-human-b7-h1-pd-l1-cd274-mdx-1105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203747-anti-human-b7-h1-pd-l1-cd274-mdx-1105-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203748-anti-human-il-17ra-cd217-brodalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203749-anti-human-il-17ra-cd217-brodalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203750-anti-human-il-17ra-cd217-brodalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203751-anti-human-alpha-synuclein-cinpanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203752-anti-human-alpha-synuclein-cinpanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203753-anti-human-alpha-synuclein-cinpanemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203754-anti-human-lif-msc-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203755-anti-human-lif-msc-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203756-anti-human-lif-msc-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203757-anti-human-tnfsf7-cd27l-cd70-vorsetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203758-anti-human-tnfsf7-cd27l-cd70-vorsetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203759-anti-human-tnfsf7-cd27l-cd70-vorsetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203760-anti-human-erbb1-egfr-her1-cetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203761-anti-human-erbb1-egfr-her1-cetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203762-anti-human-erbb1-egfr-her1-cetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203763-anti-human-cd7-persongen-patent-anti-cd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203764-anti-human-cd7-persongen-patent-anti-cd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203765-anti-human-cd7-persongen-patent-anti-cd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203766-anti-human-cd38-daratumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203767-anti-human-cd38-daratumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203768-anti-human-cd38-daratumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203769-anti-human-pdcd1-pd-1-cd279-pembrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203770-anti-human-pdcd1-pd-1-cd279-pembrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203771-anti-human-pdcd1-pd-1-cd279-pembrolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203772-anti-human-tnfrsf8-cd30-brentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203773-anti-human-tnfrsf8-cd30-brentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203774-anti-human-tnfrsf8-cd30-brentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203775-anti-human-siglec-3-cd33-lintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203776-anti-human-siglec-3-cd33-lintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203777-anti-human-siglec-3-cd33-lintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203778-anti-human-psgl1-cd162-neihulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203779-anti-human-psgl1-cd162-neihulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203780-anti-human-psgl1-cd162-neihulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203781-anti-human-acvr2b-bimagrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203782-anti-human-acvr2b-bimagrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203783-anti-human-acvr2b-bimagrumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203784-anti-human-vegf-bevacizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203785-anti-human-vegf-bevacizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203786-anti-human-vegf-bevacizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203787-anti-human-epha2-sanofi-aventis-patent-anti-epha2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203788-anti-human-epha2-sanofi-aventis-patent-anti-epha2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203789-anti-human-epha2-sanofi-aventis-patent-anti-epha2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203790-anti-human-cd20-obinutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203791-anti-human-cd20-obinutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203792-anti-human-cd20-obinutuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203793-anti-human-lilrb4-ilt3-cd85k-merck-patent-anti-ilt3-complex-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203794-anti-human-lilrb4-ilt3-cd85k-merck-patent-anti-ilt3-complex-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203795-anti-human-lilrb4-ilt3-cd85k-merck-patent-anti-ilt3-complex-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203796-anti-human-serum-amyloid-p-sap-dezamizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203797-anti-human-serum-amyloid-p-sap-dezamizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203798-anti-human-serum-amyloid-p-sap-dezamizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203799-anti-human-b7-h1-pd-l1-cd274-avelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203800-anti-human-b7-h1-pd-l1-cd274-avelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203801-anti-human-b7-h1-pd-l1-cd274-avelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203802-anti-human-nkg2d-cd314-tesnatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203803-anti-human-nkg2d-cd314-tesnatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203804-anti-human-nkg2d-cd314-tesnatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203805-anti-human-erbb2-her2-cd340-pertuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203806-anti-human-erbb2-her2-cd340-pertuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203807-anti-human-erbb2-her2-cd340-pertuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203808-anti-human-il-6-ifnb2-clazakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203809-anti-human-il-6-ifnb2-clazakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203810-anti-human-il-6-ifnb2-clazakizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203811-anti-human-dll3-dragonfly-patent-anti-dll3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203812-anti-human-dll3-dragonfly-patent-anti-dll3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203813-anti-human-dll3-dragonfly-patent-anti-dll3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203814-anti-human-pdcd1-pd-1-cd279-nivolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203815-anti-human-pdcd1-pd-1-cd279-nivolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203816-anti-human-pdcd1-pd-1-cd279-nivolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203817-anti-human-fcrn-c317-rozanolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203818-anti-human-fcrn-c317-rozanolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203819-anti-human-fcrn-c317-rozanolixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203820-anti-human-b7-h5-vista-onvatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203821-anti-human-b7-h5-vista-onvatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203822-anti-human-b7-h5-vista-onvatilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203823-anti-human-ccn2-ctgf-pamrevlumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203824-anti-human-ccn2-ctgf-pamrevlumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203825-anti-human-ccn2-ctgf-pamrevlumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203826-anti-human-il-21-lilly-patent-anti-il-21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203827-anti-human-il-21-lilly-patent-anti-il-21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203828-anti-human-il-21-lilly-patent-anti-il-21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203829-anti-human-tnfrsf10b-trailr2-cd262-conatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203830-anti-human-tnfrsf10b-trailr2-cd262-conatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203831-anti-human-tnfrsf10b-trailr2-cd262-conatumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203832-anti-human-vegfr2-kdr-cd309-ramucirumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203833-anti-human-vegfr2-kdr-cd309-ramucirumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203834-anti-human-vegfr2-kdr-cd309-ramucirumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203835-anti-human-bcl-2-u-toronto-patent-anti-bax-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203836-anti-human-bcl-2-u-toronto-patent-anti-bax-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203837-anti-human-bcl-2-u-toronto-patent-anti-bax-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203838-anti-human-acvr2a-ab-14e1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203839-anti-human-acvr2a-ab-14e1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203840-anti-human-acvr2a-ab-14e1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203841-anti-human-pdcd1-pd-1-cd279-camrelizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203842-anti-human-pdcd1-pd-1-cd279-camrelizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203843-anti-human-pdcd1-pd-1-cd279-camrelizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203844-anti-human-pmel-genentech-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203845-anti-human-pmel-genentech-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203846-anti-human-pmel-genentech-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203847-anti-human-kir-lirilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203848-anti-human-kir-lirilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203849-anti-human-kir-lirilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203850-anti-human-pdgfb-mor-8457-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203851-anti-human-pdgfb-mor-8457-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203852-anti-human-pdgfb-mor-8457-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203853-anti-human-tnfsf2-tnfa-adalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203854-anti-human-tnfsf2-tnfa-adalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203855-anti-human-tnfsf2-tnfa-adalimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203856-anti-human-nt5e-cd73-oleclumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203857-anti-human-nt5e-cd73-oleclumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203858-anti-human-nt5e-cd73-oleclumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203859-anti-human-siglec-8-lirentelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203860-anti-human-siglec-8-lirentelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203861-anti-human-siglec-8-lirentelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203862-anti-human-pmel-novartis-patent-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203863-anti-human-pmel-novartis-patent-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203864-anti-human-pmel-novartis-patent-anti-pmel17-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203865-anti-human-ly75-cd205-dec-205-cdx-1401-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203866-anti-human-ly75-cd205-dec-205-cdx-1401-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203867-anti-human-ly75-cd205-dec-205-cdx-1401-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203868-anti-human-tnfrsf9-4-1bb-cd137-urelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203869-anti-human-tnfrsf9-4-1bb-cd137-urelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203870-anti-human-tnfrsf9-4-1bb-cd137-urelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203871-anti-human-tspan26-cd37-naratuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203872-anti-human-tspan26-cd37-naratuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203873-anti-human-tspan26-cd37-naratuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203874-anti-human-lilrb4-ilt3-cd85k-u-texas-patent-anti-lilrb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203875-anti-human-lilrb4-ilt3-cd85k-u-texas-patent-anti-lilrb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203876-anti-human-lilrb4-ilt3-cd85k-u-texas-patent-anti-lilrb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203877-anti-human-il-6ra-cd126-tocilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203878-anti-human-il-6ra-cd126-tocilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203879-anti-human-il-6ra-cd126-tocilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203880-anti-human-cd19-inebilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203881-anti-human-cd19-inebilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203882-anti-human-cd19-inebilizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203883-anti-human-tem1-endosialin-cd248-ontuxizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203884-anti-human-tem1-endosialin-cd248-ontuxizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203885-anti-human-tem1-endosialin-cd248-ontuxizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203886-anti-human-b7-h3-cd276-enoblituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203887-anti-human-b7-h3-cd276-enoblituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203888-anti-human-b7-h3-cd276-enoblituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203889-anti-human-tnfrsf7-cd27-varlilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203890-anti-human-tnfrsf7-cd27-varlilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203891-anti-human-tnfrsf7-cd27-varlilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203892-anti-human-igf1r-cd221-cixutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203893-anti-human-igf1r-cd221-cixutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203894-anti-human-igf1r-cd221-cixutumumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203895-anti-human-folr1-fra-farletuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203896-anti-human-folr1-fra-farletuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203897-anti-human-folr1-fra-farletuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203898-anti-human-alcam-cd166-at002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203899-anti-human-alcam-cd166-at002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203900-anti-human-alcam-cd166-at002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203901-anti-human-tnfrsf10b-trailr2-cd262-tigatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203902-anti-human-tnfrsf10b-trailr2-cd262-tigatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203903-anti-human-tnfrsf10b-trailr2-cd262-tigatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203904-anti-human-cd5-magenta-patent-anti-cd5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203905-anti-human-cd5-magenta-patent-anti-cd5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203906-anti-human-cd5-magenta-patent-anti-cd5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203907-anti-human-tigit-tiragolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203908-anti-human-tigit-tiragolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203909-anti-human-tigit-tiragolumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203910-anti-human-erbb2-her2-cd340-trastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203911-anti-human-erbb2-her2-cd340-trastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203912-anti-human-erbb2-her2-cd340-trastuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203913-anti-human-kir3dl2-cd158k-lacutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203914-anti-human-kir3dl2-cd158k-lacutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203915-anti-human-kir3dl2-cd158k-lacutamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203916-anti-human-angpt2-nesvacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203917-anti-human-angpt2-nesvacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203918-anti-human-angpt2-nesvacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203919-anti-human-fgfr2-cd332-bemarituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203920-anti-human-fgfr2-cd332-bemarituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203921-anti-human-fgfr2-cd332-bemarituzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203922-anti-human-tnfsf13-april-cd256-bion-1301-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203923-anti-human-tnfsf13-april-cd256-bion-1301-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203924-anti-human-tnfsf13-april-cd256-bion-1301-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203925-anti-human-epha2-medi-547-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203926-anti-human-epha2-medi-547-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203927-anti-human-epha2-medi-547-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203928-anti-human-csf1-m-csf-lacnotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203929-anti-human-csf1-m-csf-lacnotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203930-anti-human-csf1-m-csf-lacnotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203931-anti-human-p-selectin-cd62p-crizanlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203932-anti-human-p-selectin-cd62p-crizanlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203933-anti-human-p-selectin-cd62p-crizanlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203934-anti-human-alcam-cd166-praluzatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203935-anti-human-alcam-cd166-praluzatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203936-anti-human-alcam-cd166-praluzatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203937-anti-human-slamf7-cs1-elotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203938-anti-human-slamf7-cs1-elotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203939-anti-human-slamf7-cs1-elotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203940-anti-human-folh1-psma-rosopatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203941-anti-human-folh1-psma-rosopatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203942-anti-human-folh1-psma-rosopatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203943-anti-human-tnfsf2-tnfa-infliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203944-anti-human-tnfsf2-tnfa-infliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203945-anti-human-tnfsf2-tnfa-infliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203946-anti-human-b7-h1-pd-l1-cd274-atezolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203947-anti-human-b7-h1-pd-l1-cd274-atezolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203948-anti-human-b7-h1-pd-l1-cd274-atezolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203949-anti-human-hgfr-c-met-amivantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203950-anti-human-hgfr-c-met-amivantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203951-anti-human-hgfr-c-met-amivantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203952-anti-human-angptl3-evinacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203953-anti-human-angptl3-evinacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203954-anti-human-angptl3-evinacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203955-anti-human-p-selectin-cd62p-inclacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203956-anti-human-p-selectin-cd62p-inclacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203957-anti-human-p-selectin-cd62p-inclacumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203958-anti-human-acvr1-alk-2-ds-6016a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203959-anti-human-acvr1-alk-2-ds-6016a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203960-anti-human-acvr1-alk-2-ds-6016a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203961-anti-human-pdcd1-pd-1-cd279-spartalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203962-anti-human-pdcd1-pd-1-cd279-spartalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203963-anti-human-pdcd1-pd-1-cd279-spartalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203964-anti-human-cd20-rituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203965-anti-human-cd20-rituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203966-anti-human-cd20-rituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203967-anti-human-tnfrsf9-4-1bb-cd137-utomilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203968-anti-human-tnfrsf9-4-1bb-cd137-utomilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203969-anti-human-tnfrsf9-4-1bb-cd137-utomilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203970-anti-human-folr1-fra-mirvetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203971-anti-human-folr1-fra-mirvetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203972-anti-human-folr1-fra-mirvetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203973-anti-human-b7-h1-pd-l1-cd274-durvalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203974-anti-human-b7-h1-pd-l1-cd274-durvalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203975-anti-human-b7-h1-pd-l1-cd274-durvalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203976-anti-human-ly75-cd205-dec-205-men1309-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203977-anti-human-ly75-cd205-dec-205-men1309-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203978-anti-human-ly75-cd205-dec-205-men1309-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203979-anti-human-gdf8-myostatin-apitegromab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203980-anti-human-gdf8-myostatin-apitegromab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203981-anti-human-gdf8-myostatin-apitegromab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203982-anti-human-amyloid-beta-crenezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203983-anti-human-amyloid-beta-crenezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203984-anti-human-amyloid-beta-crenezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203985-anti-human-tnfsf9-4-1bbl-abbvie-patent-anti-tnfsf9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203986-anti-human-tnfsf9-4-1bbl-abbvie-patent-anti-tnfsf9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203987-anti-human-tnfsf9-4-1bbl-abbvie-patent-anti-tnfsf9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203988-anti-human-fgfr2-cd332-aprutumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203989-anti-human-fgfr2-cd332-aprutumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203990-anti-human-fgfr2-cd332-aprutumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203991-anti-human-cd19-tafasitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203992-anti-human-cd19-tafasitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203993-anti-human-cd19-tafasitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203994-anti-human-hgfr-c-met-onartuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203995-anti-human-hgfr-c-met-onartuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203996-anti-human-hgfr-c-met-onartuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203997-anti-human-il-18-gsk-1070806-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203998-anti-human-il-18-gsk-1070806-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25203999-anti-human-il-18-gsk-1070806-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204000-anti-human-hgfa-genentech-patent-anti-hgfa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204001-anti-human-hgfa-genentech-patent-anti-hgfa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204002-anti-human-hgfa-genentech-patent-anti-hgfa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204003-anti-human-il-1rap-il-1r3-nidanilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204004-anti-human-il-1rap-il-1r3-nidanilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204005-anti-human-il-1rap-il-1r3-nidanilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204006-anti-human-integrin-a4b7-abrilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204007-anti-human-integrin-a4b7-abrilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204008-anti-human-integrin-a4b7-abrilumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204009-anti-human-grem1-gremlin-regeneron-patent-anti-grem1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204010-anti-human-grem1-gremlin-regeneron-patent-anti-grem1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204011-anti-human-grem1-gremlin-regeneron-patent-anti-grem1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204012-anti-human-alpha-synuclein-prasinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204013-anti-human-alpha-synuclein-prasinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204014-anti-human-alpha-synuclein-prasinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204015-anti-human-amyloid-beta-amgen-patent-anti-beta-amyloid-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204016-anti-human-amyloid-beta-amgen-patent-anti-beta-amyloid-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204017-anti-human-amyloid-beta-amgen-patent-anti-beta-amyloid-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204018-anti-human-ctla-8-il-17a-secukinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204019-anti-human-ctla-8-il-17a-secukinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204020-anti-human-ctla-8-il-17a-secukinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204021-anti-human-cxcr3-gpr9-cd183-genzyme-patent-anti-cxcr3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204022-anti-human-cxcr3-gpr9-cd183-genzyme-patent-anti-cxcr3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204023-anti-human-cxcr3-gpr9-cd183-genzyme-patent-anti-cxcr3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204024-anti-human-gfra3-nadecnemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204025-anti-human-gfra3-nadecnemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204026-anti-human-gfra3-nadecnemab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204027-anti-human-hgfr-c-met-telisotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204028-anti-human-hgfr-c-met-telisotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204029-anti-human-hgfr-c-met-telisotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204030-anti-human-tie2-cd202b-regeneron-patent-anti-tie-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204031-anti-human-tie2-cd202b-regeneron-patent-anti-tie-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204032-anti-human-tie2-cd202b-regeneron-patent-anti-tie-2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204033-anti-human-il-1b-canakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204034-anti-human-il-1b-canakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204035-anti-human-il-1b-canakinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204036-anti-human-integrin-a11-itag11-scripps-patent-anti-cd11a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204037-anti-human-integrin-a11-itag11-scripps-patent-anti-cd11a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204038-anti-human-integrin-a11-itag11-scripps-patent-anti-cd11a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204039-anti-human-tpbg-pf-06263507-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204040-anti-human-tpbg-pf-06263507-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204041-anti-human-tpbg-pf-06263507-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204042-anti-human-htra1-fhtr2163-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204043-anti-human-htra1-fhtr2163-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204044-anti-human-htra1-fhtr2163-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204045-anti-human-cdh11-cadherin-11-rg6125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204046-anti-human-cdh11-cadherin-11-rg6125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204047-anti-human-cdh11-cadherin-11-rg6125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204048-anti-human-ccr5-cd195-leronlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204049-anti-human-ccr5-cd195-leronlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204050-anti-human-ccr5-cd195-leronlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204051-anti-human-il-13-tralokinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204052-anti-human-il-13-tralokinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204053-anti-human-il-13-tralokinumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204054-anti-human-lrrc15-lib-samrotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204055-anti-human-lrrc15-lib-samrotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204056-anti-human-lrrc15-lib-samrotamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204057-anti-human-slc44a4-asg-5me-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204058-anti-human-slc44a4-asg-5me-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204059-anti-human-slc44a4-asg-5me-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204060-anti-human-tat226-genentech-patent-anti-tat226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204061-anti-human-tat226-genentech-patent-anti-tat226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204062-anti-human-tat226-genentech-patent-anti-tat226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204063-anti-human-amyloid-beta-gantenerumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204064-anti-human-amyloid-beta-gantenerumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204065-anti-human-amyloid-beta-gantenerumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204066-anti-human-complement-c5ar1-avdoralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204067-anti-human-complement-c5ar1-avdoralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204068-anti-human-complement-c5ar1-avdoralimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204069-anti-human-tmeff2-janssen-patent-anti-tmeff2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204070-anti-human-tmeff2-janssen-patent-anti-tmeff2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204071-anti-human-tmeff2-janssen-patent-anti-tmeff2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204072-anti-human-etbr-dedn6526a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204073-anti-human-etbr-dedn6526a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204074-anti-human-etbr-dedn6526a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204075-anti-human-amyloid-beta-aducanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204076-anti-human-amyloid-beta-aducanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204077-anti-human-amyloid-beta-aducanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204078-anti-human-lamp1-cd107a-sar428926-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204079-anti-human-lamp1-cd107a-sar428926-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204080-anti-human-lamp1-cd107a-sar428926-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204081-anti-human-notch3-tarextumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204082-anti-human-notch3-tarextumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204083-anti-human-notch3-tarextumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204084-anti-human-dysadherin-centrose-patent-anti-dysadherin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204085-anti-human-dysadherin-centrose-patent-anti-dysadherin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204086-anti-human-dysadherin-centrose-patent-anti-dysadherin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204087-anti-human-tnfrsf5-cd40-selicrelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204088-anti-human-tnfrsf5-cd40-selicrelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204089-anti-human-tnfrsf5-cd40-selicrelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204090-anti-human-slitrk6-sirtratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204091-anti-human-slitrk6-sirtratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204092-anti-human-slitrk6-sirtratumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204093-anti-human-tnfsf4-ox40l-cd252-amlitelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204094-anti-human-tnfsf4-ox40l-cd252-amlitelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204095-anti-human-tnfsf4-ox40l-cd252-amlitelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204096-anti-human-matriptase-oxford-bio-patent-anti-matriptase-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204097-anti-human-matriptase-oxford-bio-patent-anti-matriptase-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204098-anti-human-matriptase-oxford-bio-patent-anti-matriptase-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204099-anti-human-cx3cl1-fractalkine-quetmolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204100-anti-human-cx3cl1-fractalkine-quetmolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204101-anti-human-cx3cl1-fractalkine-quetmolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204102-anti-human-histone-h4-immunomedics-patent-anti-histone-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204103-anti-human-histone-h4-immunomedics-patent-anti-histone-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204104-anti-human-histone-h4-immunomedics-patent-anti-histone-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204105-anti-human-dsg3-forerunner-patent-anti-dsg3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204106-anti-human-dsg3-forerunner-patent-anti-dsg3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204107-anti-human-dsg3-forerunner-patent-anti-dsg3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204108-anti-human-cd3e-teplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204109-anti-human-cd3e-teplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204110-anti-human-cd3e-teplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204111-anti-human-histone-h3-immunomedics-patent-anti-histone-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204112-anti-human-histone-h3-immunomedics-patent-anti-histone-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204113-anti-human-histone-h3-immunomedics-patent-anti-histone-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204114-anti-human-gpr73-prokr1-multiple-seq-one-in-animal-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204115-anti-human-gpr73-prokr1-multiple-seq-one-in-animal-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204116-anti-human-gpr73-prokr1-multiple-seq-one-in-animal-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204117-anti-human-mrc2-cd280-copenhagen-rigshospitalet-patent-anti-uparap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204118-anti-human-mrc2-cd280-copenhagen-rigshospitalet-patent-anti-uparap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204119-anti-human-mrc2-cd280-copenhagen-rigshospitalet-patent-anti-uparap-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204120-anti-human-ano1-tmem16a-novartis-patent-anti-tmem16a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204121-anti-human-ano1-tmem16a-novartis-patent-anti-tmem16a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204122-anti-human-ano1-tmem16a-novartis-patent-anti-tmem16a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204123-anti-human-ifna1-baylor-patent-anti-ifn-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204124-anti-human-ifna1-baylor-patent-anti-ifn-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204125-anti-human-ifna1-baylor-patent-anti-ifn-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204126-anti-human-b7-h1-pd-l1-cd274-sudubrilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204127-anti-human-b7-h1-pd-l1-cd274-sudubrilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204128-anti-human-b7-h1-pd-l1-cd274-sudubrilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204129-anti-human-fcrn-batoclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204130-anti-human-fcrn-batoclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204131-anti-human-fcrn-batoclimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204132-anti-human-ly6e-rg7841-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204133-anti-human-ly6e-rg7841-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204134-anti-human-ly6e-rg7841-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204135-anti-human-kaag1-adct-901-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204136-anti-human-kaag1-adct-901-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204137-anti-human-kaag1-adct-901-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204138-anti-human-tfpi-befovacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204139-anti-human-tfpi-befovacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204140-anti-human-tfpi-befovacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204141-anti-human-b7-h1-pd-l1-cd274-manelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204142-anti-human-b7-h1-pd-l1-cd274-manelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204143-anti-human-b7-h1-pd-l1-cd274-manelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204144-anti-human-integrin-b7-itgb7-genentech-patent-anti-integrin-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204145-anti-human-integrin-b7-itgb7-genentech-patent-anti-integrin-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204146-anti-human-integrin-b7-itgb7-genentech-patent-anti-integrin-7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204147-anti-human-angpt2-zansecimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204148-anti-human-angpt2-zansecimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204149-anti-human-angpt2-zansecimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204150-anti-human-histone-h2b-immunomedics-patent-anti-histone-h2b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204151-anti-human-histone-h2b-immunomedics-patent-anti-histone-h2b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204152-anti-human-histone-h2b-immunomedics-patent-anti-histone-h2b-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204153-anti-human-cdiff-toxin-a-actoxumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204154-anti-human-cdiff-toxin-a-actoxumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204155-anti-human-cdiff-toxin-a-actoxumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204156-anti-human-tnfsf7-cd27l-cd70-cusatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204157-anti-human-tnfsf7-cd27l-cd70-cusatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204158-anti-human-tnfsf7-cd27l-cd70-cusatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204159-anti-human-b7-h1-pd-l1-cd274-sugemalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204160-anti-human-b7-h1-pd-l1-cd274-sugemalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204161-anti-human-b7-h1-pd-l1-cd274-sugemalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204162-anti-human-b7-h1-pd-l1-cd274-garivulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204163-anti-human-b7-h1-pd-l1-cd274-garivulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204164-anti-human-b7-h1-pd-l1-cd274-garivulimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204165-anti-human-il-1rl1-st2-il-33r-astegolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204166-anti-human-il-1rl1-st2-il-33r-astegolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204167-anti-human-il-1rl1-st2-il-33r-astegolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204168-anti-human-b7-h4-vtcn1-alsevalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204169-anti-human-b7-h4-vtcn1-alsevalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204170-anti-human-b7-h4-vtcn1-alsevalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204171-anti-human-angpt2-medi3617-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204172-anti-human-angpt2-medi3617-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204173-anti-human-angpt2-medi3617-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204174-anti-human-cd151-pierre-fabre-patent-anti-cd151-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204175-anti-human-cd151-pierre-fabre-patent-anti-cd151-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204176-anti-human-cd151-pierre-fabre-patent-anti-cd151-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204177-anti-human-integrin-b2-itgb2-cd18-erlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204178-anti-human-integrin-b2-itgb2-cd18-erlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204179-anti-human-integrin-b2-itgb2-cd18-erlizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204180-anti-human-dlk1-liv-1205-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204181-anti-human-dlk1-liv-1205-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204182-anti-human-dlk1-liv-1205-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204183-anti-human-calca-cgrp-fremanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204184-anti-human-calca-cgrp-fremanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204185-anti-human-calca-cgrp-fremanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204186-anti-human-klk2-kallikrein-2-jnj-69086420-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204187-anti-human-klk2-kallikrein-2-jnj-69086420-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204188-anti-human-klk2-kallikrein-2-jnj-69086420-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204189-anti-human-hla-dr-immu-114-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204190-anti-human-hla-dr-immu-114-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204191-anti-human-hla-dr-immu-114-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204192-anti-human-calca-cgrp-eptinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204193-anti-human-calca-cgrp-eptinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204194-anti-human-calca-cgrp-eptinezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204195-anti-human-abcb5-brigham-and-women-s-patent-anti-abcb5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204196-anti-human-abcb5-brigham-and-women-s-patent-anti-abcb5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204197-anti-human-abcb5-brigham-and-women-s-patent-anti-abcb5-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204198-anti-human-ptgfrn-cd315-ag02-adc-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204199-anti-human-ptgfrn-cd315-ag02-adc-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204200-anti-human-ptgfrn-cd315-ag02-adc-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204201-anti-human-bace1-genentech-anti-bace1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204202-anti-human-bace1-genentech-anti-bace1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204203-anti-human-bace1-genentech-anti-bace1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204204-anti-human-dpep3-tamrintamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204205-anti-human-dpep3-tamrintamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204206-anti-human-dpep3-tamrintamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204207-anti-human-158p1d7-agensys-patent-anti-158p1d7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204208-anti-human-158p1d7-agensys-patent-anti-158p1d7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204209-anti-human-158p1d7-agensys-patent-anti-158p1d7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204210-anti-human-b7-h3-cd276-trellis-patent-anti-b7-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204211-anti-human-b7-h3-cd276-trellis-patent-anti-b7-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204212-anti-human-b7-h3-cd276-trellis-patent-anti-b7-h3-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204213-anti-human-musk-argenx-patent-anti-musk-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204214-anti-human-musk-argenx-patent-anti-musk-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204215-anti-human-musk-argenx-patent-anti-musk-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204216-anti-human-amyloid-beta-gsk-933776-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204217-anti-human-amyloid-beta-gsk-933776-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204218-anti-human-amyloid-beta-gsk-933776-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204219-anti-human-icos-cd278-alomfilimab-biosimilar 2026-07-05T12:16:48.485Z weekly 0.9 https://gentaur.com/products/25204220-anti-human-icos-cd278-alomfilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204221-anti-human-icos-cd278-alomfilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204222-anti-human-axl-ufo-tilvestamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204223-anti-human-axl-ufo-tilvestamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204224-anti-human-axl-ufo-tilvestamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204225-anti-human-efna4-pf-06647263-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204226-anti-human-efna4-pf-06647263-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204227-anti-human-efna4-pf-06647263-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204228-anti-human-muc16-abagovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204229-anti-human-muc16-abagovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204230-anti-human-muc16-abagovomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204231-anti-human-cxc-elr-lilly-patent-anti-pan-elr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204232-anti-human-cxc-elr-lilly-patent-anti-pan-elr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204233-anti-human-cxc-elr-lilly-patent-anti-pan-elr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204234-anti-human-scfr-c-kit-cd117-cdx-0158-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204235-anti-human-scfr-c-kit-cd117-cdx-0158-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204236-anti-human-scfr-c-kit-cd117-cdx-0158-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204237-anti-human-mica-cln-619-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204238-anti-human-mica-cln-619-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204239-anti-human-mica-cln-619-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204240-anti-human-muc1-cantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204241-anti-human-muc1-cantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204242-anti-human-muc1-cantuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204243-anti-human-polyubiquitin-genentech-patent-anti-polyubiquitin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204244-anti-human-polyubiquitin-genentech-patent-anti-polyubiquitin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204245-anti-human-polyubiquitin-genentech-patent-anti-polyubiquitin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204246-anti-human-b7-h1-pd-l1-cd274-pacmilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204247-anti-human-b7-h1-pd-l1-cd274-pacmilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204248-anti-human-b7-h1-pd-l1-cd274-pacmilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204249-anti-human-siglec-3-cd33-vadastuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204250-anti-human-siglec-3-cd33-vadastuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204251-anti-human-siglec-3-cd33-vadastuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204252-anti-human-cd19-duke-u-patent-anti-cd19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204253-anti-human-cd19-duke-u-patent-anti-cd19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204254-anti-human-cd19-duke-u-patent-anti-cd19-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204255-anti-human-ccl5-rantes-ni-0701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204256-anti-human-ccl5-rantes-ni-0701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204257-anti-human-ccl5-rantes-ni-0701-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204258-anti-human-c-ret-regeneron-patent-anti-ret-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204259-anti-human-c-ret-regeneron-patent-anti-ret-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204260-anti-human-c-ret-regeneron-patent-anti-ret-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204261-anti-human-pcsk9-bococizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204262-anti-human-pcsk9-bococizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204263-anti-human-pcsk9-bococizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204264-anti-human-albumin-numab-patent-anti-hsa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204265-anti-human-albumin-numab-patent-anti-hsa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204266-anti-human-albumin-numab-patent-anti-hsa-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204267-anti-human-trem1-cd354-py159-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204268-anti-human-trem1-cd354-py159-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204269-anti-human-trem1-cd354-py159-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204270-anti-human-b7-h6-ncr3lg1-dartmouth-patent-anti-b7-h6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204271-anti-human-b7-h6-ncr3lg1-dartmouth-patent-anti-b7-h6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204272-anti-human-b7-h6-ncr3lg1-dartmouth-patent-anti-b7-h6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204273-anti-human-tfpi-concizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204274-anti-human-tfpi-concizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204275-anti-human-tfpi-concizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204276-anti-human-stop1-genentech-patent-anti-stop-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204277-anti-human-stop1-genentech-patent-anti-stop-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204278-anti-human-stop1-genentech-patent-anti-stop-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204279-anti-human-cd20-tru-015-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204280-anti-human-cd20-tru-015-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204281-anti-human-cd20-tru-015-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204282-anti-human-dpp4-cd26-begelomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204283-anti-human-dpp4-cd26-begelomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204284-anti-human-dpp4-cd26-begelomab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204285-anti-human-cb1-cnr1-nimacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204286-anti-human-cb1-cnr1-nimacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204287-anti-human-cb1-cnr1-nimacimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204288-anti-human-ifna1-chinese-cdc-patent-anti-human-interferon-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204289-anti-human-ifna1-chinese-cdc-patent-anti-human-interferon-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204290-anti-human-ifna1-chinese-cdc-patent-anti-human-interferon-alpha-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204291-anti-human-rg1-19g9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204292-anti-human-rg1-19g9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204293-anti-human-rg1-19g9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204294-anti-human-angptl4-nanyang-tech-u-patent-anti-angptl4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204295-anti-human-angptl4-nanyang-tech-u-patent-anti-angptl4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204296-anti-human-angptl4-nanyang-tech-u-patent-anti-angptl4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204297-anti-human-cxcl4-pf4-u-penn-patent-anti-pf4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204298-anti-human-cxcl4-pf4-u-penn-patent-anti-pf4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204299-anti-human-cxcl4-pf4-u-penn-patent-anti-pf4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204300-anti-human-ptk7-cck4-cofetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204301-anti-human-ptk7-cck4-cofetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204302-anti-human-ptk7-cck4-cofetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204303-anti-human-b7-h4-vtcn1-millennium-patent-anti-b7-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204304-anti-human-b7-h4-vtcn1-millennium-patent-anti-b7-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204305-anti-human-b7-h4-vtcn1-millennium-patent-anti-b7-h4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204306-anti-human-cd20-ripertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204307-anti-human-cd20-ripertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204308-anti-human-cd20-ripertamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204309-anti-human-sost-sclerostin-blosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204310-anti-human-sost-sclerostin-blosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204311-anti-human-sost-sclerostin-blosozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204312-anti-human-tlr7-u-tokyo-patent-anti-tlr7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204313-anti-human-tlr7-u-tokyo-patent-anti-tlr7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204314-anti-human-tlr7-u-tokyo-patent-anti-tlr7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204315-anti-human-klotho-beta-ngm313-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204316-anti-human-klotho-beta-ngm313-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204317-anti-human-klotho-beta-ngm313-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204318-anti-human-calca-cgrp-galcanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204319-anti-human-calca-cgrp-galcanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204320-anti-human-calca-cgrp-galcanezumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204321-anti-human-tnfrsf4-ox40-cd134-cudarolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204322-anti-human-tnfrsf4-ox40-cd134-cudarolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204323-anti-human-tnfrsf4-ox40-cd134-cudarolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204324-anti-human-cd19-coltuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204325-anti-human-cd19-coltuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204326-anti-human-cd19-coltuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204327-anti-human-ceacam5-cea-cd66e-labetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204328-anti-human-ceacam5-cea-cd66e-labetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204329-anti-human-ceacam5-cea-cd66e-labetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204330-anti-human-vegfr1-flt1-abbott-patent-anti-flt1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204331-anti-human-vegfr1-flt1-abbott-patent-anti-flt1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204332-anti-human-vegfr1-flt1-abbott-patent-anti-flt1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204333-anti-human-scfr-c-kit-cd117-lop628-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204334-anti-human-scfr-c-kit-cd117-lop628-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204335-anti-human-scfr-c-kit-cd117-lop628-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204336-anti-human-tlr3-cd283-cnto5429-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204337-anti-human-tlr3-cd283-cnto5429-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204338-anti-human-tlr3-cd283-cnto5429-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204339-anti-human-tnfsf2-tnfa-certolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204340-anti-human-tnfsf2-tnfa-certolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204341-anti-human-tnfsf2-tnfa-certolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204342-anti-human-pcsk9-boehringer-anti-pcsk9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204343-anti-human-pcsk9-boehringer-anti-pcsk9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204344-anti-human-pcsk9-boehringer-anti-pcsk9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204345-anti-human-cd20-veltuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204346-anti-human-cd20-veltuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204347-anti-human-cd20-veltuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204348-anti-human-crtam-cd355-oxford-bio-patent-anti-crtam-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204349-anti-human-crtam-cd355-oxford-bio-patent-anti-crtam-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204350-anti-human-crtam-cd355-oxford-bio-patent-anti-crtam-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204351-anti-human-rgma-elezanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204352-anti-human-rgma-elezanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204353-anti-human-rgma-elezanumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204354-anti-human-complement-c5-eculizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204355-anti-human-complement-c5-eculizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204356-anti-human-complement-c5-eculizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204357-anti-human-ccr4-cd194-mogamulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204358-anti-human-ccr4-cd194-mogamulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204359-anti-human-ccr4-cd194-mogamulizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204360-anti-human-b7-h2-icosl-cd275-prezalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204361-anti-human-b7-h2-icosl-cd275-prezalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204362-anti-human-b7-h2-icosl-cd275-prezalumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204363-anti-human-ca9-caix-girentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204364-anti-human-ca9-caix-girentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204365-anti-human-ca9-caix-girentuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204366-anti-human-cd46-for46-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204367-anti-human-cd46-for46-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204368-anti-human-cd46-for46-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204369-anti-human-il-13-cnto-607-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204370-anti-human-il-13-cnto-607-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204371-anti-human-il-13-cnto-607-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204372-anti-human-ccl5-rantes-vlst-002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204373-anti-human-ccl5-rantes-vlst-002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204374-anti-human-ccl5-rantes-vlst-002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204375-anti-human-cldn18-2-zolbetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204376-anti-human-cldn18-2-zolbetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204377-anti-human-cldn18-2-zolbetuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204378-anti-human-dcbld2-esdn-fa19-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204379-anti-human-dcbld2-esdn-fa19-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204380-anti-human-dcbld2-esdn-fa19-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204381-anti-human-cd47-magrolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204382-anti-human-cd47-magrolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204383-anti-human-cd47-magrolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204384-anti-human-cldn6-imab027-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204385-anti-human-cldn6-imab027-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204386-anti-human-cldn6-imab027-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204387-anti-human-prlr-prolactin-receptor-rolinsatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204388-anti-human-prlr-prolactin-receptor-rolinsatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204389-anti-human-prlr-prolactin-receptor-rolinsatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204390-anti-human-ctss-cathepsin-s-fsn0503h-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204391-anti-human-ctss-cathepsin-s-fsn0503h-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204392-anti-human-ctss-cathepsin-s-fsn0503h-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204393-anti-human-bst2-cd317-xmab-5592-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204394-anti-human-bst2-cd317-xmab-5592-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204395-anti-human-bst2-cd317-xmab-5592-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204396-anti-human-cdcp1-cd318-u-california-patent-anti-cdcp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204397-anti-human-cdcp1-cd318-u-california-patent-anti-cdcp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204398-anti-human-cdcp1-cd318-u-california-patent-anti-cdcp1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204399-anti-human-il-3ra-cd123-talacotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204400-anti-human-il-3ra-cd123-talacotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204401-anti-human-il-3ra-cd123-talacotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204402-anti-human-ccl20-gsk3050002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204403-anti-human-ccl20-gsk3050002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204404-anti-human-ccl20-gsk3050002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204405-anti-human-cxcr5-cd185-sar113244-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204406-anti-human-cxcr5-cd185-sar113244-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204407-anti-human-cxcr5-cd185-sar113244-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204408-anti-human-il-25-centocor-patent-anti-il-25-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204409-anti-human-il-25-centocor-patent-anti-il-25-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204410-anti-human-il-25-centocor-patent-anti-il-25-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204411-anti-human-amyloid-beta-cnto-2125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204412-anti-human-amyloid-beta-cnto-2125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204413-anti-human-amyloid-beta-cnto-2125-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204414-anti-human-clec7a-baylor-patent-anti-dectin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204415-anti-human-clec7a-baylor-patent-anti-dectin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204416-anti-human-clec7a-baylor-patent-anti-dectin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204417-anti-human-prom1-cd133-forerunner-patent-anti-prominin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204418-anti-human-prom1-cd133-forerunner-patent-anti-prominin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204419-anti-human-prom1-cd133-forerunner-patent-anti-prominin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204420-anti-human-cd79b-polatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204421-anti-human-cd79b-polatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204422-anti-human-cd79b-polatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204423-anti-human-tim-3-havcr2-cd366-cobolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204424-anti-human-tim-3-havcr2-cd366-cobolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204425-anti-human-tim-3-havcr2-cd366-cobolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204426-anti-human-cxcl10-ip-10-eldelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204427-anti-human-cxcl10-ip-10-eldelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204428-anti-human-cxcl10-ip-10-eldelumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204429-anti-human-ephb2-genentech-patent-anti-ephb2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204430-anti-human-ephb2-genentech-patent-anti-ephb2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204431-anti-human-ephb2-genentech-patent-anti-ephb2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204432-anti-human-b7-h1-pd-l1-cd274-cosibelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204433-anti-human-b7-h1-pd-l1-cd274-cosibelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204434-anti-human-b7-h1-pd-l1-cd274-cosibelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204435-anti-human-dll4-demcizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204436-anti-human-dll4-demcizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204437-anti-human-dll4-demcizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204438-anti-human-cd19-denintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204439-anti-human-cd19-denintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204440-anti-human-cd19-denintuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204441-anti-human-cd20-ublituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204442-anti-human-cd20-ublituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204443-anti-human-cd20-ublituximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204444-anti-human-cd52-alemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204445-anti-human-cd52-alemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204446-anti-human-cd52-alemtuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204447-anti-human-tnfrsf21-dr6-cd358-abbvie-patent-anti-tnfrsf21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204448-anti-human-tnfrsf21-dr6-cd358-abbvie-patent-anti-tnfrsf21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204449-anti-human-tnfrsf21-dr6-cd358-abbvie-patent-anti-tnfrsf21-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204450-anti-human-tnfrsf5-cd40-sotigalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204451-anti-human-tnfrsf5-cd40-sotigalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204452-anti-human-tnfrsf5-cd40-sotigalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204453-anti-human-cd2-siplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204454-anti-human-cd2-siplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204455-anti-human-cd2-siplizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204456-anti-human-cd20-zuberitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204457-anti-human-cd20-zuberitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204458-anti-human-cd20-zuberitamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204459-anti-human-c1s-sutimlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204460-anti-human-c1s-sutimlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204461-anti-human-c1s-sutimlimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204462-anti-human-dkk1-bhq-880-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204463-anti-human-dkk1-bhq-880-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204464-anti-human-dkk1-bhq-880-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204465-anti-human-dll4-navicixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204466-anti-human-dll4-navicixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204467-anti-human-dll4-navicixizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204468-anti-human-fgfr3-cd333-vofatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204469-anti-human-fgfr3-cd333-vofatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204470-anti-human-fgfr3-cd333-vofatamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204471-anti-human-cdh6-k-cadherin-hkt288-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204472-anti-human-cdh6-k-cadherin-hkt288-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204473-anti-human-cdh6-k-cadherin-hkt288-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204474-anti-human-gpa33-krn330-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204475-anti-human-gpa33-krn330-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204476-anti-human-gpa33-krn330-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204477-anti-human-tnfrsf5-cd40-bleselumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204478-anti-human-tnfrsf5-cd40-bleselumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204479-anti-human-tnfrsf5-cd40-bleselumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204480-anti-human-epor-abbott-patent-anti-epo-receptor-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204481-anti-human-epor-abbott-patent-anti-epo-receptor-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204482-anti-human-epor-abbott-patent-anti-epo-receptor-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204483-anti-human-dc-sign-cd209-inserm-patent-anti-dc-sign-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204484-anti-human-dc-sign-cd209-inserm-patent-anti-dc-sign-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204485-anti-human-dc-sign-cd209-inserm-patent-anti-dc-sign-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204486-anti-human-ccr2-cd192-plozalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204487-anti-human-ccr2-cd192-plozalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204488-anti-human-ccr2-cd192-plozalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204489-anti-human-ox2r-cd200r1-janssen-patent-anti-cd200r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204490-anti-human-ox2r-cd200r1-janssen-patent-anti-cd200r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204491-anti-human-ox2r-cd200r1-janssen-patent-anti-cd200r1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204492-anti-human-entpd1-cd39-ttx-030-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204493-anti-human-entpd1-cd39-ttx-030-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204494-anti-human-entpd1-cd39-ttx-030-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204495-anti-human-flt3-cd135-imc-eb10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204496-anti-human-flt3-cd135-imc-eb10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204497-anti-human-flt3-cd135-imc-eb10-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204498-anti-human-emmprin-cd147-centocor-patent-anti-cd147-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204499-anti-human-emmprin-cd147-centocor-patent-anti-cd147-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204500-anti-human-emmprin-cd147-centocor-patent-anti-cd147-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204501-anti-human-ifna1-rontalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204502-anti-human-ifna1-rontalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204503-anti-human-ifna1-rontalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204504-anti-human-fzd7-u-toronto-patent-anti-fzd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204505-anti-human-fzd7-u-toronto-patent-anti-fzd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204506-anti-human-fzd7-u-toronto-patent-anti-fzd7-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204507-anti-human-complement-c5-crovalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204508-anti-human-complement-c5-crovalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204509-anti-human-complement-c5-crovalimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204510-anti-human-fibronectin-l19-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204511-anti-human-fibronectin-l19-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204512-anti-human-fibronectin-l19-tnf-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204513-anti-human-clec14a-scripps-korea-patent-anti-clec14a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204514-anti-human-clec14a-scripps-korea-patent-anti-clec14a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204515-anti-human-clec14a-scripps-korea-patent-anti-clec14a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204516-anti-human-ncam1-cd56-lorvotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204517-anti-human-ncam1-cd56-lorvotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204518-anti-human-ncam1-cd56-lorvotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204519-anti-human-ccr7-cd197-r707-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204520-anti-human-ccr7-cd197-r707-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204521-anti-human-ccr7-cd197-r707-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204522-anti-human-fgf2-hugal-f2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204523-anti-human-fgf2-hugal-f2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204524-anti-human-fgf2-hugal-f2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204525-anti-human-fcgr2a-cd32a-vib9600-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204526-anti-human-fcgr2a-cd32a-vib9600-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204527-anti-human-fcgr2a-cd32a-vib9600-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204528-anti-human-fgfr3-cd333-ly3076226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204529-anti-human-fgfr3-cd333-ly3076226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204530-anti-human-fgfr3-cd333-ly3076226-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204531-anti-human-fgfr4-cd334-u3-1784-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204532-anti-human-fgfr4-cd334-u3-1784-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204533-anti-human-fgfr4-cd334-u3-1784-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204534-anti-human-ephb4-vasgene-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204535-anti-human-ephb4-vasgene-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204536-anti-human-ephb4-vasgene-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204537-anti-human-cd47-cc-90002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204538-anti-human-cd47-cc-90002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204539-anti-human-cd47-cc-90002-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204540-anti-human-slc40a1-amgen-patent-anti-ferroportin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204541-anti-human-slc40a1-amgen-patent-anti-ferroportin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204542-anti-human-slc40a1-amgen-patent-anti-ferroportin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204543-anti-human-gipr-amgen-patent-anti-gipr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204544-anti-human-gipr-amgen-patent-anti-gipr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204545-anti-human-gipr-amgen-patent-anti-gipr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204546-anti-human-grem1-gremlin-ucb-patent-anti-gremlin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204547-anti-human-grem1-gremlin-ucb-patent-anti-gremlin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204548-anti-human-grem1-gremlin-ucb-patent-anti-gremlin-1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204549-anti-human-cxcl9-novimmune-patent-anti-cxcl9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204550-anti-human-cxcl9-novimmune-patent-anti-cxcl9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204551-anti-human-cxcl9-novimmune-patent-anti-cxcl9-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204552-anti-human-cd200-samalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204553-anti-human-cd200-samalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204554-anti-human-cd200-samalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204555-anti-human-slc40a1-ly2928057-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204556-anti-human-slc40a1-ly2928057-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204557-anti-human-slc40a1-ly2928057-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204558-anti-human-tnfrsf18-gitr-cd357-ragifilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204559-anti-human-tnfrsf18-gitr-cd357-ragifilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204560-anti-human-tnfrsf18-gitr-cd357-ragifilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204561-anti-human-icos-cd278-feladilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204562-anti-human-icos-cd278-feladilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204563-anti-human-icos-cd278-feladilimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204564-anti-human-il-3ra-cd123-sng-cd123a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204565-anti-human-il-3ra-cd123-sng-cd123a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204566-anti-human-il-3ra-cd123-sng-cd123a-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204567-anti-human-cd69-genefrontier-patent-anti-cd69-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204568-anti-human-cd69-genefrontier-patent-anti-cd69-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204569-anti-human-cd69-genefrontier-patent-anti-cd69-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204570-anti-human-ido2-limr-patent-anti-ido2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204571-anti-human-ido2-limr-patent-anti-ido2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204572-anti-human-ido2-limr-patent-anti-ido2-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204573-anti-human-ceacam6-cd66c-neo-201-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204574-anti-human-ceacam6-cd66c-neo-201-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204575-anti-human-ceacam6-cd66c-neo-201-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204576-anti-human-ceacam1-cd66a-cm-24-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204577-anti-human-ceacam1-cd66a-cm-24-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204578-anti-human-ceacam1-cd66a-cm-24-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204579-anti-human-ephb4-morphosys-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204580-anti-human-ephb4-morphosys-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204581-anti-human-ephb4-morphosys-patent-anti-ephb4-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204582-anti-human-il-20-fletikumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204583-anti-human-il-20-fletikumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204584-anti-human-il-20-fletikumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204585-anti-human-csf3r-g-csfr-csl-patent-anti-g-csfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204586-anti-human-csf3r-g-csfr-csl-patent-anti-g-csfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204587-anti-human-csf3r-g-csfr-csl-patent-anti-g-csfr-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204588-anti-human-hbegf-khk2866-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204589-anti-human-hbegf-khk2866-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204590-anti-human-hbegf-khk2866-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204591-anti-human-il-31ra-nemolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204592-anti-human-il-31ra-nemolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204593-anti-human-il-31ra-nemolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204594-anti-human-chi3l1-brown-u-patent-anti-chi3l1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204595-anti-human-chi3l1-brown-u-patent-anti-chi3l1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204596-anti-human-chi3l1-brown-u-patent-anti-chi3l1-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204597-anti-human-klotho-beta-rg7992-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204598-anti-human-klotho-beta-rg7992-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204599-anti-human-klotho-beta-rg7992-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204600-anti-human-tnfrsf17-bcma-cd269-belantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204601-anti-human-tnfrsf17-bcma-cd269-belantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204602-anti-human-tnfrsf17-bcma-cd269-belantamab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204603-anti-human-gcgr-crotedumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204604-anti-human-gcgr-crotedumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204605-anti-human-gcgr-crotedumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204606-anti-human-il-1rl2-il-36r-spesolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204607-anti-human-il-1rl2-il-36r-spesolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204608-anti-human-il-1rl2-il-36r-spesolimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204609-anti-human-il-4-pascolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204610-anti-human-il-4-pascolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204611-anti-human-il-4-pascolizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204612-anti-human-hgfr-c-met-emibetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204613-anti-human-hgfr-c-met-emibetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204614-anti-human-hgfr-c-met-emibetuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204615-anti-human-epcam-trop1-cd326-citatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204616-anti-human-epcam-trop1-cd326-citatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204617-anti-human-epcam-trop1-cd326-citatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204618-anti-human-erbb3-her3-patritumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204619-anti-human-erbb3-her3-patritumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204620-anti-human-erbb3-her3-patritumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204621-anti-human-hbegf-u3-1565-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204622-anti-human-hbegf-u3-1565-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204623-anti-human-hbegf-u3-1565-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204624-anti-human-fgf19-1a6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204625-anti-human-fgf19-1a6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204626-anti-human-fgf19-1a6-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204627-anti-human-fap-sibrotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204628-anti-human-fap-sibrotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204629-anti-human-fap-sibrotuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204630-anti-human-csf2ra-gm-csfra-cd116-mavrilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204631-anti-human-csf2ra-gm-csfra-cd116-mavrilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204632-anti-human-csf2ra-gm-csfra-cd116-mavrilimumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204633-anti-human-csf1r-m-csfr-cd115-cabiralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204634-anti-human-csf1r-m-csfr-cd115-cabiralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204635-anti-human-csf1r-m-csfr-cd115-cabiralizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204636-anti-human-gdf8-myostatin-landogrozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204637-anti-human-gdf8-myostatin-landogrozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204638-anti-human-gdf8-myostatin-landogrozumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204639-anti-human-mesothelin-amatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204640-anti-human-mesothelin-amatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204641-anti-human-mesothelin-amatuximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204642-anti-human-il-23-guselkumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204643-anti-human-il-23-guselkumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204644-anti-human-il-23-guselkumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204645-anti-human-il-2rb-cd122-singapore-astr-patent-anti-il-2r-beta-il-2r-gamma-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204646-anti-human-il-2rb-cd122-singapore-astr-patent-anti-il-2r-beta-il-2r-gamma-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204647-anti-human-il-2rb-cd122-singapore-astr-patent-anti-il-2r-beta-il-2r-gamma-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204648-anti-human-hgf-sf-ficlatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204649-anti-human-hgf-sf-ficlatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204650-anti-human-hgf-sf-ficlatuzumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204651-anti-human-nkg2a-cd94-monalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204652-anti-human-nkg2a-cd94-monalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204653-anti-human-nkg2a-cd94-monalizumab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204654-anti-human-icos-cd278-vopratelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204655-anti-human-icos-cd278-vopratelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204656-anti-human-icos-cd278-vopratelimab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204657-anti-human-haptoglobin-khk-patent-anti-haptoglobin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204658-anti-human-haptoglobin-khk-patent-anti-haptoglobin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204659-anti-human-haptoglobin-khk-patent-anti-haptoglobin-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204660-anti-human-mmp9-andecaliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204661-anti-human-mmp9-andecaliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204662-anti-human-mmp9-andecaliximab-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204663-anti-human-lilrb2-ilt4-cd85d-jtx-8064-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204664-anti-human-lilrb2-ilt4-cd85d-jtx-8064-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9 https://gentaur.com/products/25204665-anti-human-lilrb2-ilt4-cd85d-jtx-8064-biosimilar 2026-06-03T16:46:27.204Z weekly 0.9